Schema-Root.org logo

 

  cross-referenced news and research resources about

 Abbott Laboratories

Schema-Root.org logo
images:  google   yahoo YouTube
spacer

updated Tue. February 26, 2019

-
Abbott Laboratories (ABT) addition 1.13% with the finishing price of $60.17 in Friday Trading Session. With Latest addition move, stock price showed -6.86% down in value from one year high price and revealed 42.21% upward in value from its one year low price. In the recent week Abbott Laboratories ...
Research analysts are predicting that Abbott Laboratories (NYSE:ABT) will report earnings of $0.58 per share when the firm issues their next quarterly report. This is the consensus earnings per share number according to data from Zack's Research. Abbott Laboratories (NYSE:ABT) closed the last session ...

Abbott Laboratories (NYSE: ABT) has grabbed attention from the analysts when it experienced a change of 1.13% in the last trading session to close at $60.17. A total of 7,800,306 shares exchanged hands during the intra-day trade contrast with its average trading volume of 6.96M shares, while its relative ...
Abbott Laboratories logo Starfire Investment Advisers Inc. grew its holdings in Abbott Laboratories (NYSE:ABT) by 28.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,989 shares of the healthcare product ...
On January 24, 2018, during Abbott Laboratories' (ABT) 4Q17 and fiscal 2017 earnings release, the company announced its fiscal 2018 guidance. Abbott provided a strong fiscal 2018 performance outlook, and the stock registered a rise of ~4.2% on the day of the earnings announcement. On January 24 ...
Abbott Laboratories (ABT) posted a strong earnings results on January 24, 2018, surpassing Wall Street estimates and posting earnings at the higher end of its guidance. ABT stock registered a rise of more than 4% that day. Abbott Laboratories had an eventful year in 2017, with a number of key strategic ...

On January 29, 2018, Abbott Laboratories (ABT) closed trading at $63.31 per share. The company reported its 52-week high of $64.60 on January 25, 2018. Before the earnings release, ABT stock was trading near these highs, and then the stock rose to register a 52-week high following the company's ...
Abbott Laboratories logo Abbott Laboratories (NYSE:ABT) issued an update on its FY18 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.83. Abbott ...
Abbott Laboratories logo HL Financial Services LLC reduced its holdings in Abbott Laboratories (NYSE:ABT) by 4.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 290,932 shares of the healthcare product ...
(RTTNews.com) - Abbott Laboratories ( ABT ) revealed earnings for its fourth quarter that rose compared to the same period last year. The company said its bottom line advanced to $1.30 billion, or $0.74 per share. This was higher than $0.97 billion, or $0.65 per share, in last year's fourth quarter. Analysts ...
An employee walks near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park. Daniel Acker | Bloomberg | Getty Images. An employee walks near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois. Abbott Laboratories' fourth-quarter ...
Good afternoon, everybody. It's my pleasure to introduce our next speaker on behalf of Abbott Labs. We have Brian Yoor, the Company's Executive Vice-President and Chief Financial Officer. Following Brian's remarks, we will have a break-out session in the Board's room across the hall. Brian? Brian Yoor.
Factors in Abbott Laboratories's (NYSE:ABT) current Buy recommendation is a numerical calculation of risk/reward that is attractive, analytical scoring that is near average, and a ranking in the company's industry group that is in the top quarter, and a ranking in its sector group that is in the top quarter.
Shares of Abbott Laboratories (NYSE: ABT), an Illinois-based broad range healthcare company, rose 3 percent after the company reported adjusted earnings that slightly exceeded analysts' expectations in the fourth quarter ended Dec. 31. On a GAAP basis, Abbott reported a net loss of $828 million, or 48 ...
In taking a look at some other notable technicals, Abbott Laboratories (NYSE:ABT)'s ROIC is 0.168704. The ROIC 5 year average is 0.115403 and the ROIC Quality ratio is 5.563729. ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. ROIC helps ...
Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It fall, as 47 investors sold Abbott Laboratories shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported ...
Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It turned negative, as 47 investors sold Abbott Laboratories shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 ...

Abbott Laboratories (ABT) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $57.47, up from yesterday's close by 0.82%. Given the stock's recent action, it seemed like a good time to take a closer look ...
Year-End Portfolio Pruning, Part 2: Abbott Labs: Buy The Rumor, Sell The News. Dec.19.17 | About: Abbott Laboratories (ABT) · Hale Stewart. Bonds, commodities, ETF investing, long/short equity. The Law Office of Hale Stewart. Get email alerts ...
The current recommendation of Buy for Abbott Laboratories (NYSE:ABT) has been derived by using Louis Navellier's investing methods and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking ABT has had from Portfolio Grader for 3 months.
Abbott Laboratories Makes BMO Capital's Top Picks List. Jayson Derrick , Benzinga Staff Writer {{following ? "Following" : "Follow"}}. December 12, 2017 12:34pm Comments. Share: Abbott Laboratories Makes BMO Capital's Top Picks List. Related ABT · 5 Biggest Price Target Changes For Tuesday · Benzinga's Top ...
Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs. Abbott Laboratories has a market cap of $95.11 billion; its shares were traded at around $54.64 ...
With the amassed value of the company based on its existing stock price alongside the total amount of outstanding stocks, today's market cap for Abbott Laboratories is valued at 96.17B. The value of the Market cap relatively ensures a stable and secure position for the company, and can be easily ...
Abbott Laboratories (NYSE:ABT), maintained return on investment for the last twelve months at 4.16, higher than what Reuters data shows regarding industry's average. The average of this ratio is 15.17 for the industry and sector's best figure appears 14.53. Abbott Laboratories (NYSE:ABT), at its latest ...
Abbott Laboratories (NYSE:ABT) market capitalization at present is $96.94B at the rate of $56.02 a share. The firm's price-to-sales ratio was noted 3.89 in contrast with an overall industry average of 3.94. Most of the active traders and investors are keen to find ways to compare the value of stocks.
During its 3Q17 earnings release on October 18, 2017, Abbott Laboratories (ABT) provided an updated guidance for fiscal 2017 and 4Q17. Abbott raised its fiscal 2017 guidance, and ABT stock gained ~1.3% that same day. The Vanguard Dividend Appreciation ETF (VIG) also registered a rise in its price.
After experiencing some profit-taking in the aftermath of the company's most recent earnings announcement on Oct. 18, Abbott Laboratories (NYSE:ABT) has stabilized and completed a bullish “wedge” continuation pattern on Thursday by breaking above the down-trending resistance level that started in ...
Galena Biopharma (NASDAQ: GALE) and Abbott Laboratories (NYSE:ABT) are both pharmaceuticals – nec companies, but which is the ...
Abbott Laboratories logo Zacks Investment Research upgraded shares of Abbott Laboratories (NYSE:ABT) from a hold rating to a buy rating in ...
The top gainer with a security that increased in price during today's trading was Abbott Laboratories (NYSE:ABT). Abbott Laboratories had a ...
Abbott Laboratories logo Zacks Investment Research upgraded shares of Abbott Laboratories (NYSE:ABT) from a hold rating to a buy rating in ...
Abbott Laboratories logo Abbott Laboratories (NYSE:ABT) EVP Daniel Gesua Sive Salvadori sold 96,603 shares of the company's stock in a ...
The findings of a new study just published in the Lancet counter decades of clinical experience on the use of stents to treat chest pain.
Abbott Laboratories (NYSE:ABT) closed its last session at $54. The stock traded within a range of $53.61 and $54.57. The company operates in ...
Abbott Laboratories (NYSE:ABT) plunged -0.42% with the closing price of $54.00. The overall volume in the last trading session was 7.64 ...
Eight employees of Abbott Laboratories in Little Canada have some happy hours coming their way. A group of colleagues in the medical device ...
Abbott Laboratories (ABT) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has ...
The current recommendation of Buy for Abbott Laboratories (NYSE:ABT) is computed using the system for investing of Louis Navellier and his ...
At Holdings Channel , we have reviewed the latest batch of the 21 most recent 13F filings for the 09/30/2017 reporting period, and noticed that ...
2017 saw closing of both and substantial integration of St. Jude, with the smaller Alere integration just beginning. 2018 shows great potential as ...
I love earnings season. For a few weeks every three months, investors are given a look inside of a company's fundamentals to get a chance to ...
Headquartered in Illinois, Abbott Laboratories (ABT) is one of the leading healthcare companies. It has operations in more than 150 countries ...
Good morning, and thank you for standing by. Welcome to Abbott's third quarter 2017 earnings conference call. All participants will be able to ...
Abbott Laboratories (ABT) is a true long-term outperformer. The reason for that is multifold, yet simple. Abbott is great at allocating capital, runs ...
Wall Street expects Abbott Laboratories (NYSE:ABT) to post quarterly earnings at US$0.65 a share on revenue of US$6.71bn before the ...
Abbott Laboratories (NYSE: ABT) has grabbed attention from the analysts when it experienced a change of 1.63% in the current trading session ...
Good morning and thank you for standing by. Welcome to Abbott's Third Quarter 2017 Earnings Conference Call. All participants will be able to ...
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite.
Portfolio Grader currently ranks Abbott Laboratories (NYSE:ABT) a Buy. Using Louis Navellier's investing system, this analytical tool assesses ...
Portfolio Grader currently ranks Abbott Laboratories (NYSE:ABT) a Buy. Using Louis Navellier's investing approach, this analytical tool ...


 

news and opinion


 


 


 


 


schema-root.org

     abbott laboratories

pharmaceutical industry:
     abbott laboratories
     allergan
     ariad
     astrazeneca
     baxter
     eli lilly
     glaxosmithkline
     merck
     mylan
     novartis
     pfizer
     products
     purdue pharma
     research
     takeda
     teva
     upjohn
     valeant